Centraal staat de vertaling van een ziektebeeld naar een in het laboratorium hanteerbare benadering of model om het principe of mechanisme te kunnen doorgronden.
Dit programma leidt op tot specialist in biomedisch onderzoek maar niet per se tot master gespecialiseerd in één klinisch specialisme of één methode. Men kan wel kiezen voor focus op cardiovasculair onderzoek.
The Master's programme in Biology of Disease offers the opportunity to study disease mechanisms in the broadest sense via internships in pre-clinical and clinical research in medical, biomedical, biological, industrial and veterinary labs; and to focus on more than one clinical specialty enabling you to conduct research projects on different subjects and diseases. Alternatively this programme offers the possibility to focus on cardiovascular research.
This two year research programme comprises theoretical courses, elective courses, seminars, a major and minor research project, and the writing of a Master's thesis. The core component of this two year research programme consists of independently planning and conducting the two research projects, which will take 15 months in total. The minor research project may be completed elsewhere in the Netherlands or abroad; or it may be replaced by a specific profile: Management, Teaching and Communication or Drug Regulatory Sciences. Graduates of this programme are prepared for PhD studies (approximately 65% choose for this option); or to take on a position in the medical-technical or pharmaceutical industry, or in science journalism.
Kosten
2018
|
Full-time
|
Institutioneel
|
€ 12585 / jaar
|
2018
|
Full-time
|
Internationaal
|
€ 18690 / jaar
|
2018
|
Full-time
|
Wettelijk voorgeschreven
|
€ 2060 / jaar
|
1st year
The student creates his own Master's plan. In general, the components of the Master's programme can be followed in any given order. The programme comprises 120 ECTS credits in total and can only be followed full-time. The two main components of the programme are the Major (nine months) and Minor (six months) Research projects.
admission
Het maximale aantal is 40 personen.
curriculum
In general, the components of the Master's programme can be followed in any given order.
job perspective
De meeste afgestudeerden vinden een functie op niveau.
objectives
The aim of these projects is to train students as independent researchers.
study association
Mebiose is an active and thriving association. Mebiose represents the interests of the students in education. Students regularly consult with teachers and the director of training in order to get a better education. Mebiose regularly organizes parties, excursions, seminars, a gala and various cultural and sports activities. For more information on www.mebiose.nl
tuition fee
The tuition fee for Dutch nationals is €1,906 for full-time students for the academic year 2014-2015 (statutory fee). The tuition fee for other EU/EEA and Swiss nationals is €1,906 for full-time students for the academic year 2014-2015 (statutory fee).
The tuition fee for non-EU/EEA nationals is € 18,850 for the academic year 2014-2015.
curriculum
Major research project - 9 months, Minor research project - 6 months, Master's thesis - 5 weeks
Theoretical courses of 2 weeks - 10 weeks, Mechanisms of Disease PLUS
Selection 3 of 5: Biology of Disease: Immunity and Infection, Biomolecular and Cellular Cardiology, Essentials of Neuroscience, Metabolic Disorders, Vascular Biology and Innate Immunity PLUS To choose a course from another masterprogramme
instruction modes
Research: practical work, presentations, writing report. Thesis: literature search, writing. Courses: lectures, presentations.
objectives
To produce highly skilled and scientifically able clinical researchers who are able to apply their skills to answering questions of a diverse nature across the spectrum of the biomedical sciences.
sustainable strengthening
There will be a specific answer for each graduate, but generally speaking participation in an international high quality Master programme will increase his or her professional knowledge. Since the employer plays an important role in the application procedure, it is expected that the organisation will benefit from the upgrading of its employee.